Correlation Between Caribou Biosciences and VTv Therapeutics
Can any of the company-specific risk be diversified away by investing in both Caribou Biosciences and VTv Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Caribou Biosciences and VTv Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Caribou Biosciences and vTv Therapeutics, you can compare the effects of market volatilities on Caribou Biosciences and VTv Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Caribou Biosciences with a short position of VTv Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Caribou Biosciences and VTv Therapeutics.
Diversification Opportunities for Caribou Biosciences and VTv Therapeutics
-0.08 | Correlation Coefficient |
Good diversification
The 3 months correlation between Caribou and VTv is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Caribou Biosciences and vTv Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on vTv Therapeutics and Caribou Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Caribou Biosciences are associated (or correlated) with VTv Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of vTv Therapeutics has no effect on the direction of Caribou Biosciences i.e., Caribou Biosciences and VTv Therapeutics go up and down completely randomly.
Pair Corralation between Caribou Biosciences and VTv Therapeutics
Given the investment horizon of 90 days Caribou Biosciences is expected to generate 1.04 times more return on investment than VTv Therapeutics. However, Caribou Biosciences is 1.04 times more volatile than vTv Therapeutics. It trades about 0.03 of its potential returns per unit of risk. vTv Therapeutics is currently generating about 0.01 per unit of risk. If you would invest 176.00 in Caribou Biosciences on September 23, 2024 and sell it today you would earn a total of 4.00 from holding Caribou Biosciences or generate 2.27% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Caribou Biosciences vs. vTv Therapeutics
Performance |
Timeline |
Caribou Biosciences |
vTv Therapeutics |
Caribou Biosciences and VTv Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Caribou Biosciences and VTv Therapeutics
The main advantage of trading using opposite Caribou Biosciences and VTv Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Caribou Biosciences position performs unexpectedly, VTv Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VTv Therapeutics will offset losses from the drop in VTv Therapeutics' long position.Caribou Biosciences vs. Intellia Therapeutics | Caribou Biosciences vs. Editas Medicine | Caribou Biosciences vs. Crispr Therapeutics AG | Caribou Biosciences vs. Verve Therapeutics |
VTv Therapeutics vs. Fate Therapeutics | VTv Therapeutics vs. Sana Biotechnology | VTv Therapeutics vs. Caribou Biosciences | VTv Therapeutics vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |